US pharmaceuticals company Biogen and its Japanese partner Eisai have announced they will discontinue a global Phase 3 trial for a promising Alzheimer’s disease treatment, aducanumab.

Researchers reveal the atomic structures of the tau protein, associated with chronic traumatic encephalopathy (CTE), and found that they differ in structure from those seen in Alzheimer’s disease.

Having a parent with Alzheimer’s disease has been known to raise a person’s risk of developing the disease, but new research suggests that having extended family members who have had Alzheimer’s may also increase risk.

A study published in the Journal of the American Medical Association explored the link between diet quality during midlife and dementia in 8225 participants.

New findings from Age UK show that hundreds of thousands of people, predominantly women, are taking on the majority of social care in the UK.

A study by researchers at University of Helsinki published today in the BMJ, suggests that long term use of oral hormone therapy could be associated with a small increased risk of Alzheimer’s disease in postmenopausal women.